Could very high eGFR indicate early kidney damage?

While eGFR above 90 is generally considered normal, extremely high values (>120-140) may indicate hyperfiltration, an early sign of kidney stress that can precede damage. Regular monitoring and addressing underlying causes like diabetes or hypertension is crucial for kidney health.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding eGFR and Kidney Function

The estimated glomerular filtration rate (eGFR) is one of the most important markers of kidney health, measuring how well your kidneys filter waste from your blood. While most people worry about low eGFR values indicating kidney disease, surprisingly high eGFR readings can also raise concerns. Understanding what these elevated values mean is crucial for protecting your long-term kidney health.

Your kidneys act as sophisticated filtration systems, processing about 180 liters of blood daily to remove waste products and excess fluid. The eGFR calculation estimates this filtering capacity based on your creatinine levels, age, sex, and race. While values above 90 mL/min/1.73m² are typically considered normal, extremely high readings might indicate a phenomenon called hyperfiltration.

What Is Hyperfiltration?

Hyperfiltration occurs when your kidneys work harder than normal to filter blood, resulting in an eGFR that exceeds typical healthy ranges. While there's no universal cutoff, many nephrologists consider eGFR values above 120-140 mL/min/1.73m² as potentially indicative of hyperfiltration. This increased workload might seem beneficial at first glance, but it can actually stress the delicate filtering units in your kidneys called nephrons.

eGFR Ranges and Clinical Significance

eGFR interpretation should consider individual factors including age, muscle mass, and underlying conditions.
eGFR Range (mL/min/1.73m²)InterpretationRisk LevelRecommended Action
>140>140Likely hyperfiltrationHigh risk for future declineImmediate evaluation, frequent monitoring
120-140120-140Possible hyperfiltrationModerate riskClose monitoring, address risk factors
90-12090-120Normal-highLow riskAnnual monitoring
60-8960-89Mildly reducedModerate riskRegular monitoring, lifestyle changes
<60<60Moderate to severe CKDHigh riskNephrology referral

eGFR interpretation should consider individual factors including age, muscle mass, and underlying conditions.

Think of hyperfiltration like running a car engine at maximum capacity constantly. While the engine might perform impressively in the short term, this sustained stress can lead to premature wear and eventual breakdown. Similarly, kidneys experiencing hyperfiltration may maintain excellent function initially but face increased risk of damage over time.

The Mechanism Behind Kidney Hyperfiltration

Hyperfiltration typically results from increased blood flow and pressure within the kidney's filtering units. This can occur through several mechanisms:

  • Dilation of the afferent arterioles (blood vessels entering the kidney filters)
  • Increased systemic blood pressure pushing more blood through the kidneys
  • Hormonal changes affecting kidney blood flow regulation
  • Compensatory response when some nephrons are damaged, causing remaining ones to work harder

Common Causes of Very High eGFR

Several conditions and factors can lead to hyperfiltration and elevated eGFR values. Understanding these causes helps identify who might be at risk and when to seek further evaluation.

Diabetes and Prediabetes

Early-stage diabetes is one of the most common causes of kidney hyperfiltration. High blood glucose levels trigger complex metabolic changes that increase kidney blood flow and filtration pressure. Studies show that up to 40% of people with Type 1 diabetes and 20% with Type 2 diabetes experience hyperfiltration in the early stages of their disease. This makes regular kidney function monitoring essential for anyone with diabetes or prediabetes.

Other Contributing Factors

  • Obesity: Excess weight increases metabolic demands on the kidneys
  • High protein diet: Excessive protein intake can temporarily increase filtration rates
  • Pregnancy: Normal physiological changes increase kidney filtration by 40-50%
  • Young age: Children and young adults naturally have higher eGFR values
  • Single kidney: The remaining kidney compensates by increasing its filtration rate
  • Early hypertension: High blood pressure can initially cause hyperfiltration

Why High eGFR Can Signal Future Problems

While a very high eGFR might seem like a sign of super-efficient kidneys, research reveals a more complex picture. The hyperfiltration state represents a compensatory mechanism that, while initially maintaining kidney function, can accelerate nephron damage over time. This creates a concerning progression pattern.

Studies following patients with diabetes have shown that those with initial hyperfiltration face a significantly higher risk of developing chronic kidney disease within 10-15 years compared to those with normal filtration rates. The constant stress on the kidney's filtering units leads to scarring, protein leakage, and eventual decline in function.

The Silent Progression

One of the most challenging aspects of hyperfiltration-related kidney damage is its silent nature. Patients typically experience no symptoms during the hyperfiltration phase, and standard kidney function tests might show excellent results. Only through careful monitoring over time can healthcare providers detect the subtle transition from hyperfiltration to declining kidney function.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Monitoring Your Kidney Health

Comprehensive kidney health assessment goes beyond a single eGFR measurement. A complete evaluation should include multiple markers that provide different perspectives on kidney function and potential damage.

Essential Kidney Function Tests

  • Serum creatinine: The primary marker used to calculate eGFR
  • Blood urea nitrogen (BUN): Indicates how well kidneys remove waste
  • Cystatin C: An alternative marker less affected by muscle mass
  • Urine albumin-to-creatinine ratio: Detects early protein leakage
  • Comprehensive metabolic panel: Includes electrolytes affected by kidney function

For individuals concerned about their kidney health or those with risk factors like diabetes or hypertension, regular monitoring becomes crucial. Testing every 3-6 months can help track trends and catch early changes before significant damage occurs.

When to Be Concerned About High eGFR

Not all high eGFR values warrant immediate concern. Context matters significantly when interpreting these results. However, certain situations should prompt further investigation and closer monitoring.

Red Flags to Watch For

  • eGFR consistently above 120-130 mL/min/1.73m² in adults
  • Presence of diabetes or prediabetes with high eGFR
  • Family history of kidney disease
  • Concurrent high blood pressure
  • Protein in urine (even small amounts)
  • Unexplained changes in eGFR over time

If you have any of these risk factors along with a very high eGFR, discussing your results with a healthcare provider becomes essential. They may recommend additional testing, more frequent monitoring, or preventive interventions to protect your kidney health.

Protecting Your Kidneys from Hyperfiltration Damage

The good news is that early recognition of hyperfiltration provides an opportunity for intervention before irreversible damage occurs. Several evidence-based strategies can help normalize kidney filtration rates and prevent progression to chronic kidney disease.

Lifestyle Modifications

  • Blood sugar control: Maintaining optimal glucose levels is crucial for those with diabetes
  • Blood pressure management: Keeping blood pressure below 130/80 mmHg
  • Weight management: Achieving and maintaining a healthy BMI
  • Dietary adjustments: Moderating protein intake and reducing sodium
  • Regular exercise: Improving overall metabolic health
  • Avoiding nephrotoxic substances: Including certain pain medications and supplements

Medical Interventions

For individuals with diabetes and hyperfiltration, certain medications have shown promise in normalizing kidney function. SGLT2 inhibitors, originally developed for blood sugar control, have demonstrated remarkable kidney-protective effects by reducing hyperfiltration. ACE inhibitors and ARBs, commonly used for blood pressure, also help normalize kidney filtration pressures.

The Importance of Long-Term Monitoring

Understanding your kidney health requires looking at trends over time rather than isolated test results. A single high eGFR reading might not indicate a problem, but consistently elevated values or changing patterns deserve attention. This is why establishing a baseline and tracking changes becomes so valuable for early detection and intervention.

Regular monitoring also helps healthcare providers distinguish between benign causes of high eGFR (like being young and healthy) and concerning patterns that suggest hyperfiltration. By tracking multiple kidney function markers over time, you can catch subtle changes that might otherwise go unnoticed until significant damage has occurred.

Taking Action for Kidney Health

While very high eGFR values might initially seem like a sign of excellent kidney function, they can sometimes indicate hyperfiltration—an early warning sign of potential kidney stress and future damage. This is particularly true for individuals with diabetes, obesity, or other metabolic conditions. The key lies in understanding your complete kidney health picture through comprehensive testing and regular monitoring.

By recognizing hyperfiltration early and taking appropriate action, you can protect your kidneys from long-term damage. Whether through lifestyle modifications, medical management, or simply staying vigilant with regular testing, you have the power to influence your kidney health trajectory. Remember, your kidneys work tirelessly to keep you healthy—understanding and responding to early warning signs like hyperfiltration is one of the best ways to return the favor.

References

  1. Tonneijck, L., Muskiet, M. H., Smits, M. M., van Bommel, E. J., Heerspink, H. J., van Raalte, D. H., & Joles, J. A. (2017). Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. Journal of the American Society of Nephrology, 28(4), 1023-1039.[Link][DOI]
  2. Cachat, F., Combescure, C., Cauderay, M., Girardin, E., & Chehade, H. (2015). A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clinical Journal of the American Society of Nephrology, 10(3), 382-389.[PubMed][DOI]
  3. Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012). Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nature Reviews Nephrology, 8(5), 293-300.[PubMed][DOI]
  4. Melsom, T., Mathisen, U. D., Ingebretsen, O. C., Jenssen, T. G., Njølstad, I., Solbu, M. D., & Eriksen, B. O. (2011). Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care, 34(7), 1546-1551.[PubMed][DOI]
  5. Premaratne, E., MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T., & Jerums, G. (2005). Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia, 48(12), 2486-2493.[PubMed][DOI]
  6. Cherney, D. Z., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., & Zinman, B. (2014). Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation, 129(5), 587-597.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my eGFR at home?

You can test your eGFR at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive kidney function testing with eGFR, creatinine, BUN, and cystatin C measurements, providing lab-quality results from the comfort of your home.

What is considered a dangerously high eGFR?

While there's no universal cutoff, eGFR values consistently above 120-140 mL/min/1.73m² may indicate hyperfiltration, especially in adults with diabetes or other risk factors. Values above 150 are particularly concerning and warrant immediate medical evaluation.

Can high eGFR return to normal?

Yes, high eGFR due to hyperfiltration can often normalize with proper management. Controlling blood sugar, managing blood pressure, maintaining healthy weight, and sometimes using medications like SGLT2 inhibitors can help reduce hyperfiltration and protect kidney function.

What's the difference between high eGFR and good kidney function?

While eGFR above 90 indicates good kidney function, extremely high values (>120-140) may signal hyperfiltration rather than superior health. True healthy kidney function maintains stable filtration rates without overworking the nephrons, typically between 90-110 mL/min/1.73m².

How often should I monitor my eGFR if it's very high?

If you have very high eGFR with risk factors like diabetes or hypertension, monitoring every 3-6 months is recommended. This frequency allows tracking of trends and early detection of any decline in kidney function or development of protein in the urine.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details